Hep C Virus - Diazyme Receives FDA 510(K) Approval for Enzymatic Total Bile Acids

Diazyme Receives FDA 510(K) Approval for Enzymatic Total Bile Acids
Market Wire - SAN DIEGO, CA -- (MARKET WIRE) -- 12/22/2005 -- Diazyme Laboratories, a company that applies its proprietary enzyme technologies to develop low cost and high quality diagnostic products for clinical and research uses, announced today that the U.S

New Developments in Hepatocellular Carcinoma
Medscape News - Hepatocellular carcinoma (HCC) is a major cause of mortality worldwide, resulting in an estimated 500,000 to 1 million deaths per year. [1,2] The American Cancer Society predicts that there will be 17,550 new cases and 15,420 deaths from liver and

Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved
Medical News Today - Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company's country operations in Japan, has received marketing approval for a new, additional indication for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection in

News from Health
999 Today - People pour up to 30 per cent more alcohol into short, wide glasses than tall, narrow ones of the same volume, a US study has found. Following a lumpectomy for breast cancer, radiotherapy to the breast reduces the risk of eventually dying from the

Hepatitis C Patients Taxing Medical System
HealthScout - FRIDAY, Dec. 30 (HealthDay News) -- The use of health-care resources by hepatitis C patients in the United States has been increasing by 25 percent to 30 percent a year, says a Duke University study in the December issue of Hepatology . About 3